ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,999.30
-0.23%
S&P ASX All Technology
3,160.00
-0.16%
Brent Oil
83.42
-1.09%
US Dollar vs AUD
1.48676
0.55%
Bitcoin
64,983.32
0.20%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vericel Corporation (VCEL)

  7. Vericel Corporation (VCEL) News

VCEL

Vericel (VCEL)

Vericel Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VCEL
DateTimeSourceHeadlineSymbolCompany
09/04/201423:00GlobeNewswire Inc.Aastrom Reports Data and Safety Monitoring Board Recommendation to Continue ixCELL-DCM Clinical TrialNASDAQ:VCELVericel Corporation
08/04/201422:44ZacksQuestcor Pharmaceuticals (QCOR) Shows Strength: Stock Surges 18.7% in Session - Tale of the TapeNASDAQ:VCELVericel Corporation
05/04/201407:07Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:VCELVericel Corporation
04/04/201421:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VCELVericel Corporation
04/04/201408:23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:VCELVericel Corporation
02/04/201407:56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VCELVericel Corporation
01/04/201423:30GlobeNewswire Inc.Aastrom Announces Appointments of Dr. Ross Tubo as Chief Scientific Officer and Dr. David Recker as Chief Medical OfficerNASDAQ:VCELVericel Corporation
01/04/201407:26Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:VCELVericel Corporation
27/03/201408:19Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:VCELVericel Corporation
26/03/201402:25PR Newswire (US)Pre-market Biotech Picks -- Research on Merrimack Pharma, Alexion Pharma, Incyte, and Aastrom BiosciencesNASDAQ:VCELVericel Corporation
25/03/201423:00PR Newswire (US)Candidate Selection for Clinical Trials, Financial Results, and Patient Enrollments for Phase I Study - Analyst Notes on Synt...NASDAQ:VCELVericel Corporation
22/03/201407:50Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VCELVericel Corporation
21/03/201408:26Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:VCELVericel Corporation
20/03/201400:02GlobeNewswire Inc.Aastrom Biosciences to Present at the 2014 Regen Med Investor DayNASDAQ:VCELVericel Corporation
14/03/201407:05GlobeNewswire Inc.Aastrom Biosciences Reports Fourth-Quarter and Year-End 2013 Financial ResultsNASDAQ:VCELVericel Corporation
14/03/201407:04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VCELVericel Corporation
07/03/201408:05GlobeNewswire Inc.Aastrom Biosciences to Host Fourth Quarter 2013 Investor Call on March 13, 2014NASDAQ:VCELVericel Corporation
11/02/201409:09Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:VCELVericel Corporation
28/01/201408:05GlobeNewswire Inc.Aastrom Biosciences Enters Into $15 Million Equity Commitment With Lincoln Park CapitalNASDAQ:VCELVericel Corporation
08/01/201400:57ZacksPeregrine Pharmaceuticals (PPHM) Soars: Stock Adds 14.5% in Session - Tale of the TapeNASDAQ:VCELVericel Corporation
20/12/201301:00GlobeNewswire Inc.Aastrom Biosciences Granted Composition-of-Matter Patent for Ixmyelocel-T in AustraliaNASDAQ:VCELVericel Corporation
16/11/201301:00GlobeNewswire Inc.Aastrom Biosciences Regains Compliance With NASDAQ Equity Standard Listing RequirementNASDAQ:VCELVericel Corporation
13/11/201308:05GlobeNewswire Inc.Aastrom Biosciences Reports Third-Quarter and Nine-Month 2013 Financial ResultsNASDAQ:VCELVericel Corporation
13/11/201301:00GlobeNewswire Inc.Aastrom Biosciences to Present at the 2013 Therapeutic Area Partnerships ConferenceNASDAQ:VCELVericel Corporation
08/11/201308:05GlobeNewswire Inc.Aastrom Biosciences to Host Third Quarter 2013 Investor Call on November 12, 2013NASDAQ:VCELVericel Corporation
02/11/201303:10GlobeNewswire Inc.Aastrom Announces Results of Two Studies of Ixmyelocel-T Published in Stem Cell Research & TherapyNASDAQ:VCELVericel Corporation
01/11/201300:00GlobeNewswire Inc.Aastrom Biosciences Regains Compliance With NASDAQ Minimum Bid RequirementNASDAQ:VCELVericel Corporation
17/10/201300:00GlobeNewswire Inc.Aastrom Biosciences One-for-Twenty Reverse Stock Split Now EffectiveNASDAQ:VCELVericel Corporation
11/10/201307:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VCELVericel Corporation
11/10/201307:15GlobeNewswire Inc.Aastrom Biosciences Announces One-for-Twenty Reverse Stock SplitNASDAQ:VCELVericel Corporation
 Showing the most relevant articles for your search:NASDAQ:VCEL

Your Recent History

NASDAQ
MCAGR
Mountain Crest Acquisiti...
LSE
IQSS
Ivz Qs Ge Mf Ac
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved